Yujiro S. Hata

Yujiro S. Hata

DirectoratIDEAYA Biosciences· In proxies 2021–2025

Pay in FY2025-44% from the year before · IDEAYA Biosciences stock +34.5% the same year

Yujiro S. Hata was paid $9.5M in FY2025 (Dec), down 44%. IDEAYA Biosciences stock rose 34.5% that year.

Pay$100 in the stock at the end of FY20 → $247
Pay is from the Summary Compensation Table of each IDEAYA Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Enanta PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. IDEAYA BiosciencesPublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role +163%
  3. Hexagon Bio, IncPublic company
    • Director? – PresentNo stock prices for these years
  4. Xencor, Inc.Public company · 7 yr
    • Director2015 – 2022 · 7 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?